AIDX 20/20 Biolabs, Inc.
$0.23▼ -0.39%
Healthcare
Other
Volume 174.0K
Avg Volume (10D) 172.7K
Key Metrics & Fundamentals
Market Cap
$2.96M
P/E Ratio
–
Div Yield
0.00%
52W Range
0.23 - 50.00
% vs 50 MA
-47.51%
% vs 200 MA
–%
RSI-14
22.0
MACD Histogram
+0.0000
Beta (1Y vs SPY)
0.55
Free Cash Flow
-$612,960
Gross Rev
$730,571
Gross Profit
$304,727
EBITDA
-$1.22M
COGS
$425,844
Operating Exp
$1.55M
Operating Income
-$1.24M
EBIT
-$1.24M
Pretax Income
-$1.51M
Net Income
-$1.51M
EPS (Diluted)
-0.26
Price & Volume History
Loading chart…
Recent News
20/20 BioLabs to Participate in the Maxim Growth Summit 2026 in New York on October 14, 2026
GlobeNewswire · Oct 2, 2026 8:31 AM ET
20/20 BioLabs to Host Investor Webinar on October 7, 2026 to Discuss FDA Advisory Committee Vote and New OneTest™ Franchise Model
GlobeNewswire · Sep 29, 2026 8:31 AM ET
Profound Medical Stock And 2 Canadian AI Healthcare Stocks To Watch
Simply Wall St. · Sep 5, 2026 10:14 PM ET
Healwell AI (TSX:AIDX) Stock Draws Fresh Price Target Split After Quarterly Results
Simply Wall St. · Sep 5, 2026 1:06 PM ET
20/20 BioLabs Reschedules Investor Webinar to 2:00 p.m. Eastern Time on September 2, 2026 to Discuss OneTest™ Revenue and Expanding Commercial Opportunity
GlobeNewswire · Aug 28, 2026 6:26 PM ET
20/20 BioLabs to Host Investor Webinar on September 2, 2026 to Discuss OneTest™ Revenue and Expanding Commercial Opportunity
GlobeNewswire · Aug 26, 2026 8:31 AM ET
20/20 BioLabs Reports Second Quarter 2026 Financial Results and Recent Operational Progress, as Cancer Test Revenue Reaches Record Quarterly Level
GlobeNewswire · Aug 17, 2026 8:31 AM ET
20/20 BioLabs to Host Investor Webinar on August 5, 2026, to Discuss Commercial Opportunities Following Management’s Recent East Asia Business Development Tour
GlobeNewswire · Jul 30, 2026 8:31 AM ET
Financial Overview - Income Statement
Quarterly
Jun 2026
See AIDX's money flow as a full page
Social Sentiment
Loading Reddit posts…
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.